These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 10957937)
21. Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease. Mottet C; Schoepfer AM; Juillerat P; Cosnes J; Froehlich F; Kessler-Brondolo V; Seibold F; Rogler G; Vavricka SR; Michetti P Inflamm Bowel Dis; 2016 Nov; 22(11):2733-2747. PubMed ID: 27760078 [TBL] [Abstract][Full Text] [Related]
22. Azathioprine or 6-mercaptopurine for inflammatory bowel disease: do risks outweigh benefits? Su CG; Stein RB; Lewis JD; Lichtenstein GR Dig Liver Dis; 2000; 32(6):518-31. PubMed ID: 11057928 [TBL] [Abstract][Full Text] [Related]
23. Paediatric inflammatory bowel disease: review with a focus on practice in low- to middle-income countries. Dalzell AM; Ba'Ath ME Paediatr Int Child Health; 2019 Feb; 39(1):48-58. PubMed ID: 30900526 [TBL] [Abstract][Full Text] [Related]
24. 6-mercaptopurine in patients with inflammatory bowel disease and previous digestive intolerance of azathioprine. Domènech E; Nos P; Papo M; López-San Román A; Garcia-Planella E; Gassull MA Scand J Gastroenterol; 2005 Jan; 40(1):52-5. PubMed ID: 15841714 [TBL] [Abstract][Full Text] [Related]
26. Update 2014: advances to optimize 6-mercaptopurine and azathioprine to reduce toxicity and improve efficacy in the management of IBD. Amin J; Huang B; Yoon J; Shih DQ Inflamm Bowel Dis; 2015 Feb; 21(2):445-52. PubMed ID: 25248004 [TBL] [Abstract][Full Text] [Related]
27. A national survey on the patterns of treatment of inflammatory bowel disease in Canada. Hilsden RJ; Verhoef MJ; Best A; Pocobelli G BMC Gastroenterol; 2003 Jun; 3():10. PubMed ID: 12791168 [TBL] [Abstract][Full Text] [Related]
28. Bone density improves with disease remission in patients with inflammatory bowel disease. Reffitt DM; Meenan J; Sanderson JD; Jugdaohsingh R; Powell JJ; Thompson RP Eur J Gastroenterol Hepatol; 2003 Dec; 15(12):1267-73. PubMed ID: 14624148 [TBL] [Abstract][Full Text] [Related]
30. Monitoring of AZA/6-MP treatment in children with IBD is necessary. Dubinsky MC Inflamm Bowel Dis; 2003 Nov; 9(6):386-8; discussion 392-3. PubMed ID: 14671488 [No Abstract] [Full Text] [Related]
31. The genetics of inflammatory bowel disease: diagnostic and therapeutic implications. Cuffari C World J Pediatr; 2010 Aug; 6(3):203-9. PubMed ID: 20706819 [TBL] [Abstract][Full Text] [Related]
32. The use of 6-mercaptopurine in patients with inflammatory bowel disease after failure of azathioprine therapy. Boulton-Jones JR; Pritchard K; Mahmoud AA Aliment Pharmacol Ther; 2000 Dec; 14(12):1561-5. PubMed ID: 11121903 [TBL] [Abstract][Full Text] [Related]
34. Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine. Su C; Lichtenstein GR Gastroenterol Clin North Am; 2004 Jun; 33(2):209-34, viii. PubMed ID: 15177535 [TBL] [Abstract][Full Text] [Related]
35. [Biomarkers in the diagnosis and therapy of inflammatory bowel diseases]. Iijima H; Shinzaki S; Tsujii M; Takehara T Nihon Rinsho; 2012 May; 70(5):869-73. PubMed ID: 22620015 [TBL] [Abstract][Full Text] [Related]
40. Natural history and outcome of inflammatory bowel diseases in children in Saudi Arabia: A single-center experience. Alreheili KM; Alsaleem KA; Almehaidib AI Saudi J Gastroenterol; 2018; 24(3):171-176. PubMed ID: 29676289 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]